Valion Bio (VBIO)
Develops radiation-injury immunotherapeutics and offers biologics CDMO services.
$3.02
Pre-market−0.15 (−4.67%)
At close$3.17(+3.19%)
Something off on this page? Send us feedback.
Next report
Nov 13, 2026
in 71 days
EPS estimate
−$408.00
Revenue estimate
$460.0K
Fiscal quarter
Q2 FY27
EPSReportedEstimate
May '23Nov '23May '24Nov '24Nov '25May '26Aug '26Nov '26
Reported−$1.87−$25.16−$17.17−$3.91−$0.01−$2.23−$2.17Pending
Estimate−$1.87−$119.00−$119.00−$102.00——−$408.00−$408.00
Surprise0.0%+78.9%+85.6%+96.2%——+99.5%—
RevenueReportedEstimate
May '23Nov '23May '24Nov '24Nov '25May '26Aug '26Nov '26
Reported$376.0K$282.0K$334.0K$126.0K$778.8K—$1.1MPending
Estimate$520.0K$780.0K$1.1M$1.3M——$460.0K$460.0K
Surprise−27.7%−63.8%−68.8%−90.0%——+141.2%—
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$408.00 | — | — |
| Aug 2026 | −$408.00 | −$2.17 | +99.5% |
| May 2026 | — | −$2.23 | — |
| Nov 2025 | — | −$0.01 | — |
| Nov 2025 | — | — | — |
| Mar 2025 | −$85.00 | — | — |
| Nov 2024 | −$102.00 | −$3.91 | +96.2% |
The latest year is open to everyone — the 39 quarters behind it read with an account. Sign in | |||
| May 2024 | |||
| Nov 2023 | |||
| May 2023 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Jan 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| Jun 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| Jul 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| Jun 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| Jun 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| Jun 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Jun 2015 | |||
| Feb 2015 | |||
| Nov 2014 | |||
| Aug 2014 | |||
| Jun 2014 | |||
| Feb 2014 | |||
| Nov 2013 | |||
| Aug 2013 | |||
| May 2013 | |||
| Feb 2013 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | −$408.00 | — | — | $460.0K | — | — | — |
| Aug 14, 2026 | −$408.00 | −$2.17 | +99.5% | $460.0K | $1.1M | +141.2% | +11.5% |
| May 14, 2026 | — | −$2.23 | — | — | — | — | −5.5% |
| Nov 15, 2025 | — | −$0.01 | — | — | $778.8K | — | −21.5% |
| Nov 14, 2025 | — | — | — | — | — | — | — |
| Mar 20, 2025 | −$85.00 | — | — | $1.4M | — | — | — |
| Nov 14, 2024 | −$102.00 | −$3.91 | +96.2% | $1.3M | $126.0K | −90.0% | −21.2% |
The latest year is open to everyone — the 39 quarters behind it read with an account. Sign in | |||||||
| May 15, 2024 | |||||||
| Nov 14, 2023 | |||||||
| May 15, 2023 | |||||||
| Nov 15, 2021 | |||||||
| Aug 13, 2021 | |||||||
| May 19, 2021 | |||||||
| Jan 29, 2021 | |||||||
| Nov 13, 2020 | |||||||
| Aug 14, 2020 | |||||||
| Jun 29, 2020 | |||||||
| Feb 14, 2020 | |||||||
| Nov 14, 2019 | |||||||
| Aug 13, 2019 | |||||||
| Jul 15, 2019 | |||||||
| Feb 14, 2019 | |||||||
| Nov 14, 2018 | |||||||
| Aug 14, 2018 | |||||||
| Jun 28, 2018 | |||||||
| Feb 14, 2018 | |||||||
| Nov 14, 2017 | |||||||
| Aug 10, 2017 | |||||||
| Jun 28, 2017 | |||||||
| Feb 14, 2017 | |||||||
| Nov 17, 2016 | |||||||
| Aug 16, 2016 | |||||||
| Jun 24, 2016 | |||||||
| Feb 16, 2016 | |||||||
| Nov 16, 2015 | |||||||
| Aug 14, 2015 | |||||||
| Jun 25, 2015 | |||||||
| Feb 17, 2015 | |||||||
| Nov 14, 2014 | |||||||
| Aug 14, 2014 | |||||||
| Jun 30, 2014 | |||||||
| Feb 14, 2014 | |||||||
| Nov 5, 2013 | |||||||
| Aug 13, 2013 | |||||||
| May 20, 2013 | |||||||
| Feb 15, 2013 | |||||||